| PERIOD ENDING | 31-Oct-09 | 31-Oct-08 | 31-Oct-07 | | Total Revenue | 323,000 | 691,000 | 761,000 | | Cost of Revenue | 215,000 | 384,000 | 421,000 | | | Gross Profit | 108,000 | 307,000 | 340,000 | | | Operating Expenses | | Research Development | 92,000 | 103,000 | 91,000 | | Selling General and Administrative | 117,000 | 154,000 | 145,000 | | Non Recurring | 26,000 | 2,000 | 5,000 | | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (109,000) | 48,000 | 99,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 4,000 | (8,000) | 15,000 | | Earnings Before Interest And Taxes | (123,000) | 40,000 | 114,000 | | Interest Expense |
-
|
-
|
-
| | Income Before Tax | (123,000) | 40,000 | 114,000 | | Income Tax Expense | 4,000 | 12,000 | 17,000 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (127,000) | 28,000 | 97,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (127,000) | 28,000 | 97,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($127,000) | $28,000 | $97,000 |
|
0.02% Nasdaq 0.00%
Income Statement
